Stay updated on IRX-2 Regimen and Durvalumab Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.

Latest updates to the IRX-2 Regimen and Durvalumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added to the history, indicating a new page version. The older funding notice and Revision: v3.4.1 were removed, reflecting routine maintenance of the record history.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a government funding/status notice banner and updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check28 days agoChange DetectedUI and metadata enhancements include a 'Show glossary' option, a new color-coding legend for additions and deletions, and an updated revision banner showing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check42 days agoChange DetectedA new revision label v3.3.4 was added and the previous v3.3.3 revision was removed from the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page footer now shows a new revision label: Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 label have been removed from the footer.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded a new version entry (34) in the Record History with an updated Study Status, reflecting the trial's latest state.SummaryDifference0.3%

Stay in the know with updates to IRX-2 Regimen and Durvalumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.